Spyre Therapeutics Inc. (SYRE) support and resistance · $7.60B cap
Spyre Therapeutics Inc. (SYRE) is a biotechnology company listed on NASDAQ.
This page maps Spyre Therapeutics Inc. (SYRE) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported SYRE revenue for 2025-12-31 was $0. Net income was -$155.2M. SYRE currently screens at market cap $7.60B.
SYRE currently screens at market cap $7.60B. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new SYRE 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the SYRE quote page for the session range and the stock page for the full model.
Not investment advice.